Analysts expect Monopar Therapeutics to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 287,201.08 | 1.03 M | 3.62 M | 3.94 M | 21.66 M | 21.44 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 250,828.16 | 922,335.72 | 3.03 M | 3.48 M | 17.72 M | 18.29 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 269,014.62 | 978,645.00 | 3.32 M | 3.71 M | 19.69 M | 19.87 M |
Analysts expect Monopar Therapeutics to report earnings per share of -0.84 for Q3 26, against a range of -0.91 to -0.77. The most recent reported quarter, Q2 26, came in at -0.62, a 3.3% miss against the -0.60 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.37 | -2.74 | -0.38 | -0.35 | -0.48 | -0.64 | -0.46 | -0.62 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.86 | -0.36 | -0.60 | -0.39 | -0.37 | -0.48 | -0.81 | -0.54 | -0.77 | -1.03 | -1.11 | -1.28 | -0.98 | -1.05 | -0.25 | -0.46 | ||||||||||
| Low Estimate | -1.02 | -0.38 | -0.72 | -0.47 | -0.45 | -0.52 | -0.89 | -0.66 | -0.91 | -1.17 | -1.33 | -1.38 | -1.06 | -1.17 | -0.29 | -0.50 | ||||||||||
| Consensus Estimate | -0.94 | -0.37 | -0.66 | -0.43 | -0.41 | -0.50 | -0.85 | -0.60 | -0.84 | -1.10 | -1.22 | -1.33 | -1.02 | -1.11 | -0.27 | -0.48 |
Pull Wall Street consensus for Monopar Therapeutics (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=MNPR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "MNPR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=MNPR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();